Profilo
Frédéric Dumais is currently the Director of Communications & Investor Relations at ChitogenX, Inc., Director of Communications & Investor Relations at Valeo Pharma, Inc., and a Member of the Québec Bar Association.
In the past, he held positions as Director of Communications & Investor Relations at Liminal BioSciences, Inc., Vice President of Investor Relations at LAB International, Inc. and Akela Pharma, Inc., and Head of Investor Relations at Janssen Pharmaceutica NV.
Posizioni attive di Frédéric Dumais
| Società | Posizione | Inizio |
|---|---|---|
| VALEO PHARMA INC. | Contatto Relazioni con gli Investitori | 01/06/2019 |
| CHITOGENX INC. | Contatto Relazioni con gli Investitori | 01/06/2019 |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Corporate Officer/Principal | - |
Precedenti posizioni note di Frédéric Dumais
| Società | Posizione | Fine |
|---|---|---|
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Public Communications Contact | 13/07/2007 |
| LIMINAL BIOSCIENCES INC. | Contatto Relazioni con gli Investitori | - |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Contatto Relazioni con gli Investitori | - |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Liminal BioSciences, Inc.
Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Health Technology |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Finance |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
ChitogenX, Inc.
ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
Valeo Pharma, Inc.
Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
















